Significant reductions were obtained after 4 weeks of intervention participation for those experimental group patients with relatively low starting baseline values ( baseline item mean value < 3.31 and 3.22 , respectively ) and after 8 weeks for most patients ( approximately 75 % ) with moderate starting baseline values ( baseline item mean value < 7.30 and 5.34 , respectively ) .